Veradigm (NASDAQ:MDRX) Price Target Lowered to $15.00 at TD Cowen

Veradigm (NASDAQ:MDRXFree Report) had its target price reduced by TD Cowen from $26.00 to $15.00 in a report published on Tuesday, Benzinga reports. TD Cowen currently has a buy rating on the software maker’s stock.

A number of other research firms have also commented on MDRX. StockNews.com assumed coverage on shares of Veradigm in a research note on Saturday. They issued a hold rating on the stock. Deutsche Bank Aktiengesellschaft restated a hold rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Veradigm presently has an average rating of Hold and an average target price of $12.00.

Read Our Latest Research Report on MDRX

Veradigm Trading Up 15.9 %

Shares of NASDAQ:MDRX opened at $8.75 on Tuesday. The company’s fifty day moving average price is $7.79 and its 200 day moving average price is $9.02. Veradigm has a 12 month low of $5.01 and a 12 month high of $14.09.

Institutional Trading of Veradigm

Hedge funds and other institutional investors have recently made changes to their positions in the company. Charles Schwab Investment Management Inc. boosted its holdings in shares of Veradigm by 8.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,087,605 shares of the software maker’s stock valued at $21,899,000 after acquiring an additional 171,199 shares in the last quarter. Creative Planning raised its position in shares of Veradigm by 2,848.4% in the third quarter. Creative Planning now owns 474,376 shares of the software maker’s stock valued at $6,233,000 after buying an additional 458,287 shares during the last quarter. Kent Lake Capital LLC raised its position in shares of Veradigm by 62.2% in the fourth quarter. Kent Lake Capital LLC now owns 1,500,000 shares of the software maker’s stock valued at $15,735,000 after buying an additional 575,000 shares during the last quarter. Burney Co. raised its position in shares of Veradigm by 652.8% in the third quarter. Burney Co. now owns 234,094 shares of the software maker’s stock valued at $3,076,000 after buying an additional 202,999 shares during the last quarter. Finally, Pacer Advisors Inc. raised its position in shares of Veradigm by 108.1% in the fourth quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after buying an additional 1,307,024 shares during the last quarter.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Articles

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.